UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM8-K
CURRENTREPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):August21, 2017
Nuvectra Corporation
(Exact Name of Registrant as Specified in its Charter)
Delaware | 001-37525 | 30-0513847 |
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification Number) |
5830Granite Parkway, Suite 1100,
Plano, Texas 75024
(Address of principal executive offices, including zip code)
(214) 474-3103
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of theSecurities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of theSecurities Exchange Act of 1934 (§240.12b-2 of this chapter).
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of theExchange Act.☒
Item 1.01 | Entry into a Material Definitive Agreement. |
On August 21, 2017, Greatbatch Ltd. (“Greatbatch”) executed and delivered to Nuvectra Corporation (“Nuvectra”) an Amendment No. 1 to the Supply Agreement, with an effective date of July 21, 2017 (the “Amendment”). The Amendment amends theSupply Agreement between Nuvectra (formerly QiG Group, LLC) andGreatbatch dated March 14, 2016 (the “Supply Agreement”). Under the terms of theAmendment,Greatbatch andNuvectra agreed to modify the pricing of certain products and the amount of minimum product purchases required to be purchased byNuvectra on an annual basis fromGreatbatch.
The foregoing description is not complete and is qualified in its entirety by reference to the full text of theAmendment, which is filed as Exhibit10.1 to this Current Report and incorporated by reference into this Item 1.01.
Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
| Exhibit No. | Description |
| | |
10.1 | Amendment No. 1 to theSupply Agreement, fully executed on August21, 2017 and effective as of July 21, 2017, between Nuvectra Corporation and Greatbatch Ltd.± |
± Confidential treatment has been requested for certain portions of thisExhibit pursuant to Rule 24b-2 of theSecurities Exchange Act of 1934, as amended, which portions have been omitted and filed separately with the Securities and Exchange Commission.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
August 23, 2017 | NUVECTRA CORPORATION |
| |
| |
| By: /s/ Walter Z. Berger |
| Walter Z. Berger, |
| Chief Operating Officer and Chief Financial Officer |
| | |
EXHIBIT INDEX
| Exhibit No. | Description |
| | |
10.1 | Amendment No. 1 to the Supply Agreement, fully executed on August 21, 2017 and effective as of July 21, 2017, between Nuvectra Corporation and Greatbatch Ltd.± |
± Confidential treatment has been requested for certain portions of this Exhibit pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended, which portions have been omitted and filed separately with the Securities and Exchange Commission.
